Table 2. Type-specific prevalence of human papillomavirus (HPV) in vaginal samples by HPV vaccination status.

	Prevalence (95% CI)
	Vaccinated			Unvaccinated			Prevalence ratio (95% CI)	Adjusted prevalence ratio (95% CI)
	N	%	cii	N	%	cii
Total*	239	100		73	100
Any HPV type	92	38.5	(32.3–45.0)	30	41.1	(29.7–53.2)	0.94 (0.62–1.41)	0.97 (0.63–1.48)
HPV16 or 18	1	0.4	(0.0–2.3)	3	4.1	(0.8–11.5)	0.10 (0.01–0.98)	0.11 (0.01–1.30)
HPV6, 11, 16 or 18	1	0.4	(0.0–2.3)	5	6.8	(2.3–15.3)	0.06 (0.01–0.52)	0.04 (0.00–0.42)
High-risk types	46	19.2	(14.4–24.8)	14	19.2	(10.9–30.1)	1.00 (0.55–1.83)	1.07 (0.58–1.99)
Low-risk types	77	32.2	(26.3–38.5)	23	31.5	(21.1–43.4)	1.02 (0.64–1.63)	1.03 (0.64–1.67)
Non-vaccine-targeted types	92	38.5	(32.3–45.0)	28	38.4	(27.2–50.5)	1.00 (0.66–1.53)	1.04 (0.67–1.61)

*Participants with multiple infections were counted in each category in which their type-specific HPV infection(s) belonged. CI: confidence interval